OTC · Drug Manufacturers - Specialty & Generic

MariMed Inc. (MRMD) Stock

$0.07 +2.27% OTC: MRMD Healthcare

MariMed Inc. operates in the cannabis industry, specializing in the cultivation, production, and sale of both medicinal and adult-use cannabis items throughout the United States and internationally.

Valuation

MetricValue
Price$0.07
Market Cap$26.95M
P/E Ratio-2.11
P/B Ratio0.55
P/S Ratio0.17
EPS (TTM)$-0.04
52-Week High$0.23
52-Week Low$0.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-23.32%
ROA-6.28%
ROCE-0.67%
Gross Margin36.02%
Operating Margin-0.57%
Net Margin-7.82%
Debt/Equity1.88
Current Ratio0.95

Annual Financials (USD)

Metric20212022202320242025
Revenue$121.0M$134.0M$149.0M$158.0M$160.0M
Operating Profit$27.0M$20.0M$15.0M$3.0M$-2.0M
Net Profit$7.0M$13.0M$-16.0M$-12.0M$-14.0M
EPS$0.02$0.04$-0.04$-0.03$-0.04
Op Margin22.1%15.2%10.2%1.8%-1.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$123.0M$152.0M$196.0M$207.0M$203.0M
Total Liabilities$87.0M$95.0M$126.0M$147.0M$153.0M
Cash$30.0M$10.0M$15.0M$7.0M$9.0M
Borrowings$24.0M$37.0M$80.0M$88.0M$100.0M

Latest News

MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers GlobeNewswire · Aug 6, 2026 MariMed Announces Second Quarter 2026 Earnings Date GlobeNewswire · Jul 15, 2026 MariMed’s Betty’s Eddies™ Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins GlobeNewswire · Jul 14, 2026 MariMed’s Nature’s Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign GlobeNewswire · Jul 7, 2026 MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses GlobeNewswire · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$36.0M$7.0M$8.0M$7.0M$8.0M
Investing Cash Flow$-35.0M$-39.0M$-46.0M$-30.0M$-3.0M
Financing Cash Flow$0$-2.0M$-3.0M$0$0
Net Cash Flow$27.0M$-20.0M$5.0M$-7.0M$2.0M
Free Cash Flow$17.0M$-5.0M$-13.0M$-6.0M$7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.09
EV / EBITDA10.23
FCF Yield22.55%
Quick Ratio0.34
Interest Coverage-0.12
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held14.60%
Institutions Held0.24%
Institutions Float Held0.28%
Institutional HolderSharesReport Date
Canton Hathaway, LLC645,1002026-06-30
Ransom Advisory, Ltd321,6932025-12-31
Game Plan Financial Advisors, Llc1002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About MariMed Inc.

MariMed Inc. operates in the cannabis industry, specializing in the cultivation, production, and sale of both medicinal and adult-use cannabis items throughout the United States and internationally. The company's diverse product portfolio includes cannabis flowers and concentrates marketed under the Nature's Heritage brand. It also offers infused goods such as chewable tablets and powdered drink mixes under the Kalm Fusion label, natural fruit chews known as Betty's Eddies, and a line of baked treats like brownies and cookies available through Bubby's Baked. Furthermore, MariMed develops cannabidiol (CBD) products under the Florance brand. Beyond its own offerings, the company licenses its various brands and product formulations to others and leases facilities designed for cannabis operations. MariMed Inc., founded in 2011, is based in Norwood, Massachusetts.

MariMed Inc. is headquartered in US.

MariMed Inc. (MRMD) stock trades at $0.07 with a market capitalization of $26.95M. The stock is valued at a price-to-earnings (P/E) ratio of -2.11, price-to-book of 0.55, price-to-sales of 0.17. Over the past 52 weeks the stock has ranged between $0.06 and $0.23, and currently trades 69.6% below its 52-week high.

On profitability, MariMed Inc. generates a return on equity (ROE) of -23.32%, return on capital employed of -0.67%, an operating margin of -0.57%, a net profit margin of -7.82%.

Official website: www.marimedinc.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides